Kamada Ltd is Israel based company, focused on plasma-derived protein therapeutics with a commercial product portfolio and a late-stage product pipeline. The Company uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins.
公司代碼KMDA
公司名稱Kamada Ltd
上市日期Aug 01, 2005
CEOLondon (Amir)
員工數量374
證券類型Ordinary Share
年結日Aug 01
公司地址2 Holtzman St., Science Park
城市REHOVOT
上市交易所NASDAQ OMX - NASDAQ BASIC
國家Israel
郵編7670402
電話97289406472
網址https://www.kamada.com/
公司代碼KMDA
上市日期Aug 01, 2005
CEOLondon (Amir)